FS
Simonetta, Federico
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Incidence and Risk Factors for Infection in Heart Transplant Recipients on Posttransplant Extracorporeal Membrane Oxygenation (ECMO) | Transplantation direct | 2025 | 6 | 28 | |||
| Comparing variable and feature selection strategies for prediction - protocol of a simulation study in low-dimensional transplantation data | PloS one | 2025 | 14 | 75 | |||
| Reintegration Into the Workforce After Kidney Transplantation Based on Urbanization Status in Switzerland | Kidney international reports | 2025 | 102 | 159 | |||
| Blood virome after allogeneic hematopoietic stem cell transplantation | Open forum infectious diseases | 2025 | 58 | 94 | |||
| Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis | Kidney international reports | 2025 | 49 | 178 | |||
| Isolation measures during the COVID-19 pandemic in transplant units may decrease respiratory infection rates and improve non-relapse mortality | Bone marrow transplantation | 2025 | 5 | 0 | |||
| Invasive Candida infections in solid organ transplant recipients between 2008 and 2020 | American Journal of Transplantation | 2025 | 19 | 58 | |||
| Surgical site infections, risk factors, and outcomes after liver transplant | JAMA network open | 2025 | 72 | 187 | |||
| Time-of-day dependency of adoptive cell therapies | Trends in cancer | 2025 | 8 | 112 | |||
| Utility of the 2024 best practice recommendations from the EBMT Cellular Therapy and Immunobiology Working Party for use of donor lymphocyte infusions after allogeneic hematopoietic stem cell transplantation | Bone marrow transplantation | 2024 | 82 | 0 | |||
| Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia : a case report | Frontiers in immunology | 2024 | 34 | 60 | |||
| Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation : a case report | Frontiers in immunology | 2024 | 59 | 122 | |||
| Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT | Bone marrow transplantation | 2024 | 48 | 0 | |||
| Molecular imaging of acute graft-versus-host disease | The Journal of nuclear medicine | 2024 | 87 | 147 | |||
| A novel mitochondrial pyruvate carrier inhibitor drives stem cell-like memory CAR T cell generation and enhances antitumor efficacy | Molecular therapy. Oncology | 2024 | 193 | 161 | |||
| Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy | Cell | 2024 | 974 | 279 | |||
| Severe anaphylaxis after chimeric antigen receptor T-cell injection : a case report | EJHaem | 2024 | 54 | 112 | |||
| Granulocyte-Macrophage Colony-Stimulating Factor in Allogenic Hematopoietic Stem Cell Transplantation : From Graft-versus-Host Disease to the Graft-versus-Tumor Effect | Transplantation and cellular therapy | 2024 | 74 | 166 | |||
| Id3 keeps the PD-1 checkpoint in check in GVHD | Blood | 2024 | 56 | 0 | |||
| Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies : basic considerations and best practice recommendations from the EBMT | The lancet. Haematology | 2024 | 81 | 0 | |||
| Infectious disease events in people with HIV receiving kidney transplantation : Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study | BMC infectious diseases | 2024 | 64 | 110 | |||
| How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma? | Hematological oncology | 2024 | 110 | 102 | |||
| BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort Study | American journal of transplantation | 2024 | 48 | 92 | |||
| Single-cell transcriptomics reveal different maturation stages and sublineage commitment of human thymic invariant natural killer T cells | Journal of leukocyte biology | 2024 | 96 | 70 | |||
| Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3) | The Journal of infectious diseases | 2024 | 520 | 516 | |||
| Surgical site infections after kidney transplantation are independently associated with graft loss | American journal of transplantation | 2024 | 57 | 167 | |||
| NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivation | Blood advances | 2024 | 112 | 70 | |||
| Selective haematological cancer eradication with preserved haematopoiesis | Nature | 2024 | 144 | 79 | |||
| Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study | Frontiers in immunology | 2023 | 158 | 48 | |||
| Prevention of acute GVHD using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T cells in vivo | Blood | 2023 | 78 | 30 | |||
| Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption | Frontiers in oncology | 2023 | 71 | 116 | |||
| CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation | Leukemia & lymphoma | 2023 | 74 | 72 | |||
| Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocol | Diagnostic and prognostic research | 2023 | 77 | 181 | |||
| Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia | Leukemia | 2023 | 77 | 77 | |||
| Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma | Viruses | 2023 | 153 | 124 | |||
| Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | 2023 | 92 | 79 | |||
| Multimodal Immunomonitoring of Hematopoietic Stem Cell Transplantation and Cellular Therapies for Hematological Malignancies | 2023 | 96 | 218 | ||||
| Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | 2023 | 140 | 93 | |||
| The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort study | Frontiers in immunology | 2022 | 187 | 93 | |||
| An epigenetic signature in CD19-CAR T cells predicts clinical outcome | Trends in cancer | 2022 | 186 | 0 | |||
| Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantation | Frontiers in immunology | 2022 | 116 | 95 | |||
| Analysis of T cell Repertoire and Transcriptome Identifies Mechanisms of Regulatory T cell (Treg) Suppression of GvHD | Blood | 2022 | 501 | 142 | |||
| A National Survey Comparing Patients' and Transplant Professionals' Research Priorities in the Swiss Transplant Cohort Study | Transplant international | 2022 | 210 | 118 | |||
| Use of statins after liver transplantation is associated with improved survival: results of a nationwide study | Alimentary pharmacology & therapeutics | 2022 | 149 | 219 | |||
| Killers on the loose : Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment | International review of cell and molecular biology | 2022 | 61 | 0 | |||
| IL-2 receptor engineering enhances regulatory T cell function suppressed by calcineurin inhibitor | American journal of transplantation | 2022 | 49 | 97 | |||
| Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective Study | Transplantation and cellular therapy | 2022 | 137 | 165 | |||
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | 2022 | 241 | 120 | |||
| ICOS immunoPET enables visualization of activated T cells and early diagnosis of murine acute gastrointestinal GvHD | Blood advances | 2022 | 181 | 302 | |||
| RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia | Leukemia | 2022 | 142 | 70 | |||
| T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | 2022 | 261 | 122 | |||
| Multiparameter longitudinal imaging of immune cell activity in chimeric antigen receptor T cell and checkpoint blockade therapies | ACS central science | 2022 | 55 | 25 | |||
| Dual cytokine blockade in acute GVHD | Blood | 2021 | 206 | 1 | |||
| The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft | Bone marrow transplantation | 2021 | 349 | 0 | |||
| Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation | Frontiers in immunology | 2021 | 169 | 183 | |||
| Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-Priming | Clinical cancer research | 2021 | 211 | 191 | |||
| Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET | Clinical cancer research | 2021 | 227 | 228 | |||
| Imaging alloreactive T cells provides early warning of organ transplant rejection | JCI insight | 2021 | 205 | 90 | |||
| Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance | The Journal of clinical investigation | 2021 | 197 | 213 | |||
| Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients | Bone marrow transplantation | 2021 | 338 | 2 | |||
| Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects | Blood | 2021 | 212 | 1 | |||
| Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018 | Antimicrobial resistance and infection control | 2021 | 382 | 146 | |||
| Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD | Blood advances | 2021 | 131 | 214 | |||
| Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients | Medical mycology | 2021 | 358 | 1 | |||
| AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia | Cancers | 2021 | 208 | 88 | |||
| Suivi immunologique des patients traités par cellules CAR-T pour hémopathie maligne: recommandations du groupe CARTi et de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) | Bulletin du cancer | 2021 | 232 | 304 | |||
| Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion | Frontiers in Immunology | 2020 | 253 | 194 | |||
| Viral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy | Molecular Therapy Oncolytics | 2020 | 241 | 248 | |||
| Torque Teno Virus as a potential biomarker for complications and survival after allogeneic hematopoietic stem cell transplantation | Frontiers in Immunology | 2020 | 558 | 193 | |||
| MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors | JCI Insight | 2020 | 193 | 0 | |||
| Visualization of activated T cells by OX40-immunoPET as a strategy for diagnosis of acute Graft-versus-Host-Disease | Cancer Research | 2020 | 207 | 205 | |||
| Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease | Frontiers in Immunology | 2019 | 253 | 263 | |||
| Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway | JCI Insight | 2019 | 272 | 303 | |||
| Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Immunology | 2019 | 355 | 154 | |||
| Engineered immune cells as highly sensitive cancer diagnostics | Nature Biotechnology | 2019 | 230 | 1 | |||
| A rare case of immune thrombocytopenia secondary to breast cancer | Clinical Case Reports | 2019 | 331 | 135 | |||
| Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation | Leukemia and Lymphoma | 2018 | 544 | 2 | |||
| Central nervous system graft-versus-host disease (CNS-GvHD) after allogeneic haematopoietic stem cell transplantation | BMJ Case Reports | 2018 | 435 | 1 | |||
| Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome | Bone Marrow Transplantation | 2018 | 455 | 0 | |||
| Human pegivirus persistence in the human blood virome after allogeneic haematopoietic stem cell transplantation | Clinical Microbiology and Infection | 2018 | 1,395 | 593 | |||
| Successful treatment of refractory lupus nephritis by the sequential use of rituximab and belimumab | Joint bone spine | 2017 | 652 | 1 | |||
| Torque Teno Virus Load and Acute Rejection after Orthotopic Liver Transplantation | Transplantation | 2017 | 844 | 0 | |||
| Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation | Frontiers in Immunology | 2017 | 258 | 378 | |||
| Syndrome hémophagocytaire réactionnel | Revue médicale suisse | 2017 | 546 | 382 | |||
| Reversible encephalopathy with photoparoxysmal response during imipenem/cilastatin treatment | Journal of the Neurological Sciences | 2016 | 356 | 0 | |||
| Modulation of T-bet and Eomes during Maturation of Peripheral Blood NK Cells Does Not Depend on Licensing/Educating KIR | Frontiers in immunology | 2016 | 565 | 232 | |||
| Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants | Bone marrow transplantation | 2016 | 677 | 4 | |||
| Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Immunology | 2016 | 514 | 286 | |||
| Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies | Bone marrow transplantation | 2016 | 508 | 2 | |||
| T-bet and Eomesodermin in NK Cell Development, Maturation, and Function | Frontiers in immunology | 2016 | 560 | 473 | |||
| Complete and sustained remission of spondyloarthritis after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome | Joint bone spine | 2015 | 613 | 2 | |||
| Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab | Annals of hematology | 2015 | 609 | 2 | |||
| NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin | The Journal of immunology | 2015 | 556 | 3 | |||
| High eomesodermin expression among CD57+ CD8+ T cells identifies a CD8+ T cell subset associated with viral control during chronic human immunodeficiency virus infection | Journal of virology | 2014 | 544 | 0 |
